Literature DB >> 12852431

Retinal ganglion cells and neuroprotection for glaucoma.

Leonard A Levin1.   

Abstract

Neuroprotection is a therapeutic strategy directed at keeping retinal ganglion cells (RGCs) alive and functional. This article discusses three commonly asked questions about neuroprotection and attempts to answer them in the context of our current understanding of the pathophysiology of RGC loss in glaucomatous optic neuropathy.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12852431     DOI： 10.1016/s0039-6257(03)00007-9

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN： 0039-6257            Impact factor:   6.048


  24 in total

1.  Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo.

Authors:  Li Guo; Thomas E Salt; Annelie Maass; Vy Luong; Stephen E Moss; Fred W Fitzke; M Francesca Cordeiro
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-02       Impact factor: 4.799

Review 2.  Neuroprotection in glaucoma: drug-based approaches.

Authors:  William Cheung; Li Guo; M Francesca Cordeiro
Journal:  Optom Vis Sci       Date:  2008-06       Impact factor: 1.973

3.  Neuroprotective effect of latanoprost on rat retinal ganglion cells.

Authors:  Hideyo Kudo; Toru Nakazawa; Masahiko Shimura; Hidetoshi Takahashi; Nobuo Fuse; Kenji Kashiwagi; Makoto Tamai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-01-13       Impact factor: 3.117

4.  Topically administered timolol and dorzolamide reduce intraocular pressure and protect retinal ganglion cells in a rat experimental glaucoma model.

Authors:  M Seki; T Tanaka; H Matsuda; T Togano; K Hashimoto; J Ueda; T Fukuchi; H Abe
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

5.  Edible seaweed, Eisenia bicyclis, protects retinal ganglion cells death caused by oxidative stress.

Authors:  Kyung-A Kim; Sang Min Kim; Suk Woo Kang; Sang Il Jeon; Byung Hun Um; Sang Hoon Jung
Journal:  Mar Biotechnol (NY)       Date:  2012-05-18       Impact factor: 3.619

6.  Neuroprotection of retinal ganglion cells with GDNF-Loaded biodegradable microspheres in experimental glaucoma.

Authors:  Jian-He Xiao; Mao-Nian Zhang
Journal:  Int J Ophthalmol       Date:  2010-09-18       Impact factor: 1.779

7.  Neuroprotective effects of bis(7)-tacrine against glutamate-induced retinal ganglion cells damage.

Authors:  Jia Hua Fang; Xing Hua Wang; Zhi Rong Xu; Fa Gang Jiang
Journal:  BMC Neurosci       Date:  2010-03-03       Impact factor: 3.288

8.  Rapid and noninvasive imaging of retinal ganglion cells in live mouse models of glaucoma.

Authors:  Joaquin Tosi; Nan-Kai Wang; Jin Zhao; Chai Lin Chou; J Mie Kasanuki; Stephen H Tsang; Takayuki Nagasaki
Journal:  Mol Imaging Biol       Date:  2009-11-24       Impact factor: 3.488

9.  Laser-induced ocular hypertension in albino CD-1 mice.

Authors:  Christine T Fu; David Sretavan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-08       Impact factor: 4.799

10.  Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: Implications for glaucoma.

Authors:  Alessandro Lambiase; Luigi Aloe; Marco Centofanti; Vincenzo Parisi; Sonia Nair Báo; Flavio Mantelli; Valieria Colafrancesco; Gian Luca Manni; Massimo Gilberto Bucci; Stefano Bonini; Rita Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-11       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.